Medical Devices News and Research

RSS

Roche, OrbiMed, McKinsey announce fifteen finalists of SEED Competition

Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai’s Zhangjiang Hi-Tech Park on March 2, 2010. The event was managed and presented by ChinaBio® Accelerator. The finalists will go on to compete for the grand prize of RMB 300,000 to be presented at the SEED Final Competition and Award Ceremony in Shanghai on April 23, 2010.

6 Mar 2010

In White House meeting, Sebelius urges insurers to release all details on rate hikes

Insurance companies should disclose more information about how they spend money to justify their rate hikes, Health and Human Services Secretary Kathleen Sebelius told a group of insurance executives during a White House meeting Thursday, the San Francisco Chronicle reports.

6 Mar 2010

Stentys receives CE Marking for its self-expanding and disconnectable stent

Medical device pioneer Stentys announced today that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS).

5 Mar 2010

AMICAS and Merge Healthcare sign definitive merger agreement

AMICAS, Inc. and Merge Healthcare Incorporated (Nasdaq: MRGE) today announced that they will enter into a definitive merger agreement pursuant to which Merge will acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, or an aggregate of $248 million.

5 Mar 2010

Harmful health IT malfunctions

With the new health care IT technology already in use, preparation for the accompanying consequences should be on every family’s mind, advises Martine Ehrenclou, author of the multiple award-winning, self-help guide Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive (Lemon Grove Press).

5 Mar 2010

TSO3 new generation sterilizers allowed CE Mark labeling

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that documentation supplied to the European Notified Body conforms to the new Medical Device Directive for Class IIb medical devices; an enhanced European standard to be enforced starting April 2010. This notification allows the Company to label its new generation sterilizers with the CE Mark, which is a requirement to place products in the European Union; the second largest sterilization market after the United States.

5 Mar 2010

TransMedics closes $36M financing round

TransMedics, Inc., a leading medical device company focusing on delivering the next standard of care for solid organ transplantation worldwide, announced today the closing of a $36 million financing round. The financing was lead by Foundation Capital and Kleiner Perkins Caufield & Byers (KPCB) and also included investments by Flagship Ventures and by several existing investors.

5 Mar 2010

MetroLaser introduces new portable scanning laser Doppler vibrometer

MetroLaser is pleased to introduce the VibroMet(TM) 500 SLDV, the first truly portable scanning laser Doppler vibrometer. The vibrometer enables a user to perform a complete point-by-point vibrational analysis of any surface from a distance up to 5 meters without touching it. This system can be transported, set up, and operated by one person in real-world conditions.

4 Mar 2010

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

4 Mar 2010

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Biomoda, Inc. (www.biomoda.com) and Advanced Medical Imaging and Genetics (www.amigenics.com), an innovative medical clinic specializing in prevention and early detection of disease, announced their intent to collaborate on a variety of projects to advance technology for the early detection of lung and other cancer.

4 Mar 2010

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.

3 Mar 2010

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s DNA Vaccines 2010 in New Orleans, LA concerning the formulation and topical administration of the DermaVir therapeutic vaccine for HIV/AIDS. DNA Vaccine 2010 invites leading scientists to report on the latest research in the progressive field of DNA or Genetic Vaccines.

3 Mar 2010

Solos Endoscopy signs agreement with ER for CE Mark Technical File development consulting services

Solos Endoscopy, Inc. is pleased to announce the Company has signed an agreement with Expert Resource (ER) to provide consulting services in support of the Company's CE Mark Technical File development. Before Solos can place the CE Marking on their medical devices and legally sell within the European Union (EU) and Canada, the Company must prepare a Technical File with evidence of compliance to the EU Medical Device Directive.

3 Mar 2010

NPS Pharmaceuticals sells royalty rights from sales of REGPARA to DRI Capital's fund

NPS Pharmaceuticals, Inc. today announced the sale of its royalty rights from sales of REGPARA® (cinacalcet HCl) to a fund managed by DRI Capital, Inc., (Fund) for $38.4 million. Royalties in excess of cumulative royalties of $96 million or 2.5 times the upfront purchase price have been retained by NPS.

3 Mar 2010

TechniScan launches clinical study to assess clinical utility of Warm Bath Ultrasound

TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, today announced that in collaboration with University Medical Center Freiburg in Germany, it has launched a clinical study to assess clinical utility of TechniScan's Warm Bath Ultrasound.

3 Mar 2010

Major tech firms join ranks of health IT squad

"The race to streamline online access to medical records turned into a stampede this week as leading high-tech vendors trumpeted new initiatives at the Health Information and Management Systems Society" (HIMSS) trade show in Atlanta," InternetNews.com/Datamation reports, adding that Dell, Google, IBM, Microsoft and others are touting "new and pending deals designed to help consumers, doctors and hospital move to more easily accessible, but also secure, medical histories and information online" (Needle, 3/1).

3 Mar 2010

Biomoda receives U.S patent for cancer and pre-cancer cell based diagnostic assay

Biomoda, Inc. (www.biomoda.com) was today awarded U.S. patent 7,670,799, entitled, "Composition and Method for Making 5, 10, 15, 20- Tetrakis (Carboxyphenyl) Porphine (TCPP)" directed to Biomoda's proprietary TCPP formulation for cancer and pre-cancer cell identification and analysis and a method of making the TCPP formulation.

2 Mar 2010

Cleveland HeartLab completes $3.0M fundraising round

Cleveland HeartLab LLC (CHL) today announced that it has completed a $3.0-million fundraising round. The company’s new shareholders include local business leaders, and Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC.

2 Mar 2010

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.

2 Mar 2010

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.

2 Mar 2010

Medical Devices News and Research

Roche, OrbiMed, McKinsey announce fifteen finalists of SEED Competition

In White House meeting, Sebelius urges insurers to release all details on rate hikes

Stentys receives CE Marking for its self-expanding and disconnectable stent

AMICAS and Merge Healthcare sign definitive merger agreement

Harmful health IT malfunctions

TSO3 new generation sterilizers allowed CE Mark labeling

TransMedics closes $36M financing round

MetroLaser introduces new portable scanning laser Doppler vibrometer

Natus Medical reports increased revenue for 2009 fourth quarter

Biomoda and Amigenics collaborate to advance treatments for lung and other cancer

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Solos Endoscopy signs agreement with ER for CE Mark Technical File development consulting services

NPS Pharmaceuticals sells royalty rights from sales of REGPARA to DRI Capital's fund

TechniScan launches clinical study to assess clinical utility of Warm Bath Ultrasound

Major tech firms join ranks of health IT squad

Biomoda receives U.S patent for cancer and pre-cancer cell based diagnostic assay

Cleveland HeartLab completes $3.0M fundraising round

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Industry Focus eBook - Medical Devices (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News